Wealthcare Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$659K Buy
549
+20
+4% +$20.4K 0.27% 76
2026
Q1
$486K Hold
529
0.23% 88
2025
Q4
$568K Buy
529
+1
+0.2% +$956 0.27% 75
2025
Q3
$403K Buy
528
+200
+61% +$149K 0.19% 99
2025
Q2
$256K Buy
+328
New +$255K 0.13% 123

Other funds holding LLY

Wealthcare Capital Partners's LLY Position: Q2 2026 in Review

Wealthcare Capital Partners increased its Eli Lilly (LLY) stake by 3.8% in Q2 2026, buying an estimated $20.4K and bringing the position to 549 shares worth $659K. The position accounts for 0.27% of the portfolio, ranked #76.

Wealthcare Capital Partners first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealthcare Capital Partners held 549 shares of Eli Lilly worth $659K as of Q2 2026.
  • Wealthcare Capital Partners bought 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 0.27% of Wealthcare Capital Partners's portfolio in Q2 2026, its #76 holding.
  • Wealthcare Capital Partners first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealthcare Capital Partners's 13F filing for Q2 2026, filed 9 Jul 2026.